Goldust 2019.

Methods	Randomised controlled clinical trial study, 4 were randomly assigned to receive combination therapy (efficacy assessments were performed)
Participants	48 patients with moderate‐to‐severe plaque psoriasis
Interventions	In this 24‐week study, intervention 1: adalimumab sc 80 mg at weeks 1 and 2 then 40 mg every 2 weeks intervention 2: no intervention or placebo ?? Co‐intervention: methotrexate 15 – 20 mg a week or methotrexate monotherapy
Outcomes	PASI Hospital Anxiety and Depression scale
Notes	ABSTRACT